Company profile

Incorporated in
Fiscal year end
Former names
Merck & Co. Inc., Schering Plough Corp
IRS number

MRK stock data



8 May 19
17 Jun 19
31 Dec 19


Company financial data Financial data

Quarter (USD) Mar 19 Dec 18 Sep 18 Jun 18
Revenue 10.82B 11B 10.79B 10.47B
Net income 2.92B 1.83B 1.95B 1.71B
Diluted EPS 1.12 0.69 0.73 0.63
Net profit margin 26.95% 16.61% 18.07% 16.31%
Net change in cash 111M 139M 2.52B 827M
Cash on hand 8.08B 7.97B 7.83B 5.31B
Cost of revenue 3.05B 3.29B 3.62B 3.42B
Annual (USD) Dec 18 Dec 17 Dec 16 Dec 15
Revenue 42.29B 40.12B 39.81B
Net income 6.22B 2.39B 3.92B 4.44B
Diluted EPS 2.32 0.87 1.41 1.56
Net profit margin 14.71% 5.97% 9.85%
Net change in cash 1.87B -423M -2.01B 1.08B
Cash on hand 7.97B 6.09B 6.52B 8.52B
Cost of revenue 13.51B 12.91B 14.03B 14.93B

Financial data from Merck & Co. earnings reports

Content analysis ?
H.S. sophomore Avg
New words: ability, abused, Albrecht, Antelliq, antitrust, aprepitant, arbitration, archived, arm, await, BC, Beach, bilateral, BLA, body, bringing, buying, capecitabine, cattle, chemoradiation, CMA, compel, competing, conditionally, contemplated, contested, cough, cytotoxic, declaratory, Delaware, diagnosed, digital, Dohme, dominant, Emend, employing, engineered, explicit, exploring, False, fight, fiscal, fluoropyrimidine, gather, gBRCAm, gefapixant, German, germline, GmbH, HABP, Hamburg, hindsight, housing, implicit, incremental, indirect, infused, infusion, intent, issuance, Italian, Kingdom, larger, leader, learned, leaseback, LP, magistrate, main, Mexican, mg, Milan, misrepresented, movement, MSP, nausea, newly, Nexium, noncancellable, noninferiority, officially, OlympiAD, optimizing, ORR, parasitic, percent, pet, plant, POLO, polymorphic, preclinical, prepaid, Prilosec, Prosecution, rationalization, Rebecca, Registered, relationship, rent, repay, repayment, retailer, Rolling, salt, Schering, SCLC, session, Sharp, Smith, spent, stipulated, Sublease, topline, traceability, Utah, VABP, vacated, vehicle, Vioxx, Virginia, vivo, vomiting, XR, ZVex
Removed: Advisory, affirming, age, agent, aggregated, agreeing, Apotex, appealing, apply, arising, arose, ASCO, Asia, AUD, austerity, Australian, automatic, award, awarded, awarding, axitnib, backlog, basket, begin, borrow, borrowed, Brazil, BRCA, Brian, capitalize, Cavatak, CDC, channel, CHMP, classification, clawback, closely, Cogan, cohort, colistimethate, Colistin, collect, collection, commercialized, commonly, comparability, comparison, competitor, conducted, conjugate, consolidation, context, continuing, controlling, core, Counsel, counterclaim, coupon, criteria, CRL, damaged, dating, de, declaration, declining, decreased, deductible, defer, deferred, dental, depict, designed, disaggregate, disaggregated, discontinued, disoproxil, disproportionate, disruption, distribution, doravirine, Ebola, efficiency, elbasvir, eliminate, eliminated, eliminating, elimination, EMA, emergency, enablement, enacted, enactment, endometrial, England, enhanced, entrance, EPO, equitable, escrow, EUAL, exclusive, experienced, extraction, farm, favorably, Fee, finalized, fourth, frequent, fulfill, fully, fumarate, Galper, Gilead, GILTI, grazoprevir, half, Harvoni, HCV, healing, healthy, hearing, hexavalent, highly, history, Idenix, identifiable, imipenem, Immunization, immunogenicity, incident, indefinitely, indemnification, independent, infect, infected, infringing, initially, initiate, insuring, interpretation, intratumoral, introduction, invalid, inventory, investee, investigating, investigational, invoice, invoiced, Ireland, issue, jaw, Journal, Kenilworth, kill, lack, lamivudine, Lancet, leading, legislation, legislatively, Liaison, licensed, Listing, making, mandated, matured, Medicine, mentioned, merger, mesylate, modification, month, mutation, Nasonex, nationwide, nephrotoxicity, NewLink, NJ, noncontrolling, nonfinancial, Northern, Norway, older, oncolytic, ONJ, opening, opposed, opposition, ordered, Organization, originally, outbreak, overturn, Pacific, partnership, pay, payback, pneumococcal, Pneumovax, point, polyvalent, pool, Portugal, preferential, preferentially, prejudgment, PRIME, principle, producer, programmed, prohibition, promise, Propecia, Proscar, provisional, publicly, published, qualifying, rapid, rare, ratably, rebate, reclassification, recognizing, reconciling, referred, refractory, regimen, region, registration, reimbursed, reimbursement, reinvestment, rejected, relapsed, releasing, relebactam, remediation, repaid, replenish, replenished, replenishment, requirement, resolve, restated, retrospectively, reverse, revoked, Sanofi, satisfied, sBLA, scale, seasoned, SEC, secondary, settled, shelf, shipment, shipping, simplify, simultaneously, slightly, sofosbuvir, sought, sourced, Sovaldi, Spain, spanning, step, stockpile, stranded, streamline, subtotal, suffered, suspected, tablet, targeting, TCJA, technical, temporary, tenofovir, title, tolerability, tooth, toxicity, traded, transcriptase, transit, transparency, unaffected, unbudgeted, undistributed, unenforceable, unit, unresectable, unsettled, usage, user, utilization, utilize, vacant, validated, validity, vesting, virology, wholesaler, York, Zepatier, Zostavax, zoster